Greece: Green relief for pain
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Green relief for pain

The multi-member Civil Court of Athens recently issued an interesting judgment regarding the criteria when comparing composite trade marks covering pharmaceutical products and consisting of words and coloured devices. The dispute in question referred to a main lawsuit filed against a Greek company regarding infringement of the famous trademark Aspiring. The plaintiff claimed that the colour combination of green and white with black lettering is widely recognisable by consumers as an essential element of its Aspiring product marking and that this combination is associated with the plaintiff. The infringing product was a pharmaceutical product for the relief of pain, antipyretics and analgesic which circulated in the market in a packaging bearing the colours green and white with black lettering and under a different word mark.

The adversary claimed that many other trade marks covering pharmaceutical products and namely analgesics circulate in the EU market in packages bearing the colour combination green and white, all of which are imported and circulate in Greece as well. Therefore this colour combination cannot be associated solely with the plaintiff.

The Court ruled that in the packaging of a product the dominant element is the word part and not the colour combination. Moreover it ruled that the colour green is selected for the packaging of analgesic products because according to psychological studies and behaviour studies, this colour has been linked in the public consciousness with the idea of pain relief and is related to the feelings the different colours consciously or subconsciously cause to consumers. In view of the above, the Court rejected the plaintiff's main action.

This decision is interesting because the Court when issuing its judgment adopted a scientific reasoning and raised the issue that exclusive trade mark rights cannot be asserted for certain colour combinations when they are subconsciously connected to a treatment. Moreover the Court also took into consideration the status of the infringing company being a well-known Greek pharmaceutical company.

Maria Kilimiris

Patrinos & Kilimiris

7, Hatziyianni Mexi Str.

GR-11528 Athens


Tel: +30210 7222906, 7222050

Fax: +30210 7222889

more from across site and ros bottom lb

More from across our site

The firm also plans to build an entertainment practice group and up its IP and antitrust offerings with a focus on foreign clients
An intimate understanding of a client’s sector is essential to winning new business, a survey of over 28,000 corporate counsel reveals
Counsel say a Federal Circuit ruling on the obviousness test for design patents may increase the time IP owners spend defending their rights
With INTA Annual Meeting over for another year, here are a few things Managing IP learned after attending IP’s biggest party
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Four sources reveal which tools they have been using – or building – to help them with a range of tasks from invention generation to claim sufficiency
Managing IP reveals Wednesday's highlights, including a discussion on how AI is helping lawyers improve their "gut instinct" trademark decisions
Managing IP reveals Tuesday’s highlights, including an illuminating discussion celebrating women in the workplace and the challenges that remain
Dana Northcott, INTA’s 2024 president and associate general counsel for Amazon's IP team, talks about her work for the association
Managing IP reveals highlights from the INTA Annual Meeting, including law firms’ diversity and ESG concerns and a new beginning for a Chinese firm
Gift this article